Martin S Obin

Title: Martin S Obin: Innovator in Leukocyte Adhesion Inhibition

Introduction

Martin S Obin is a notable inventor based in Newton Centre, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of polypeptides that modulate neutrophil functions. His work has implications for anti-inflammatory therapies and the treatment of conditions involving vascular endothelium damage.

Latest Patents

Martin S Obin holds 1 patent, which is titled [ALA IL-8].sub.77 and [SER IL-8].sub.72 as Leukocyte adhesion inhibitors. This novel polypeptide, [Ala IL-8].sub.77, serves as a potent modulator of neutrophil functions. The patent details the amino acid and nucleotide sequences of the factor, along with methods for its purification, recombinant production, and pharmaceutical applications. The polypeptide and its related compositions are designed for use as anti-inflammatory agents.

Career Highlights

Throughout his career, Martin has worked with prestigious institutions, including Brigham and Women's Hospital, Inc. and Genentech, Inc. His research has focused on developing innovative solutions to complex medical challenges, particularly in the realm of inflammation and tissue repair.

Collaborations

Martin has collaborated with esteemed colleagues such as Michael A Gimbrone, Jr. and Joffre B Baker. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Martin S Obin's work in the field of leukocyte adhesion inhibition represents a significant advancement in therapeutic options for inflammatory conditions. His contributions continue to influence the landscape of biomedical research and innovation.